# Crosstalk between macrophages and fibroblasts contributes to inflammation and damage in giant cell arteritis

**Authors:** Shuang Xu, William F Jiemy, Anqi Zhang, Fokke Walinga, Miranda Nijenhuis, Elien Hensema, Wayel Abdulahad, Kornelis SM van der Geest, Peter Heeringa, Annemieke Boots, Elisabeth Brouwer, Maria Sandovici

PMC · DOI: 10.1093/rheumatology/keaf408 · Rheumatology (Oxford, England) · 2025-08-07

## TL;DR

Macrophages and fibroblasts interact in giant cell arteritis, promoting inflammation and tissue damage, with serum tenascin-C showing potential as a diagnostic biomarker.

## Contribution

This study reveals a novel crosstalk mechanism between macrophages and fibroblasts in GCA pathogenesis and identifies tenascin-C as a potential biomarker.

## Key findings

- Pro-inflammatory CD90+IL-6+ fibroblasts are spatially associated with macrophages in GCA-affected arteries.
- GM-CSF and M-CSF derived from macrophages upregulate inflammatory and extracellular matrix genes in fibroblasts.
- Serum tenascin-C levels are significantly elevated in GCA patients and show good diagnostic accuracy.

## Abstract

Giant cell arteritis (GCA) is a large vessel vasculitis characterized by arterial wall inflammation and remodelling. Macrophages and fibroblasts are abundantly present in arteries affected by GCA, but their crosstalk in GCA pathogenesis is largely unknown. Here we investigated the interaction between macrophages and fibroblasts in GCA-affected arteries and in vitro.

Immunostaining was performed to detect macrophages (CD68, CD206, FRβ), fibroblasts (CD90, CD200), GM-CSF, M-CSF, IL-6, MMP-3 and tenascin-C in GCA-positive temporal arteries (n = 9) and aorta tissues (n = 9). Serum tenascin-C levels were measured by ELISA in GCA patients (n = 36) and healthy controls (n = 46). In vitro, monocytes isolated from peripheral blood mononuclear cells of healthy donors (n = 10) were incubated with GM-CSF or M-CSF for 8 days to induce macrophage differentiation. GM-CSF/M-CSF-macrophage-conditioned medium (MCM) was added to human aortic adventitial fibroblast (HAoAF) cultures for 24 h. mRNA expression of proinflammatory cytokines(IL-6, IL-1β), growth factors (GM-CSF, M-CSF), matrix metalloproteinase (MMP-1, MMP-3), chemokines (CCL2, CX3CL1), extracellular matrix proteins (Col1a1, Col1a2, Col3a1, fibronectin-1, tenascin-C) and phenotypic markers (fibroblast activation protein [FAP], podoplanin [PDPN], α-smooth muscle actin, CD200) in cultured fibroblasts were examined by qPCR.

In GCA-affected arteries, pro-inflammatory CD90+IL-6+ fibroblasts, but not pro-resolving CD90+CD200+ fibroblasts, were spatially associated with macrophages. Adventitial CD90+ fibroblasts expressed GM-CSF and/or M-CSF, which linked to macrophage subset distribution. In vitro, both GM-CSF- and, to a lesser extent, M-CSF-derived MCM upregulated mRNA expression of IL-6, GM-CSF, M-CSF, CCL2, PDPN and CD200 in fibroblasts. Upregulation of IL-1β, MMP-3, Col3a1 and tenascin-C and downregulation of FAP in fibroblasts was observed with GM-CSF-derived MCM. Adventitial CD90+ fibroblasts in GCA-affected temporal arteries also expressed MMP-3 and tenascin-C. Serum levels of tenascin-C in patients with treatment-naïve GCA were significantly higher than those in healthy controls, showing a good diagnostic accuracy (area under the curve 0.89).

The interaction between fibroblasts and macrophages may contribute to the chronicity and progression of GCA and deserves further investigation. Serum tenascin-C is a candidate biomarker for GCA diagnosis.

## Linked entities

- **Genes:** CD68 (CD68 molecule) [NCBI Gene 968], MRC1 (mannose receptor C-type 1) [NCBI Gene 4360], THY1 (Thy-1 cell surface antigen) [NCBI Gene 7070], CD200 (CD200 molecule) [NCBI Gene 4345], CSF2 (colony stimulating factor 2) [NCBI Gene 1437], CSF1 (colony stimulating factor 1) [NCBI Gene 1435], IL6 (interleukin 6) [NCBI Gene 3569], MMP3 (matrix metallopeptidase 3) [NCBI Gene 4314], Tnc (tenascin C) [NCBI Gene 21923], IL1B (interleukin 1 beta) [NCBI Gene 3553], CCL2 (C-C motif chemokine ligand 2) [NCBI Gene 6347], CX3CL1 (C-X3-C motif chemokine ligand 1) [NCBI Gene 6376], COL1A1 (collagen type I alpha 1 chain) [NCBI Gene 1277], COL1A2 (collagen type I alpha 2 chain) [NCBI Gene 1278], COL3A1 (collagen type III alpha 1 chain) [NCBI Gene 1281], FAP (fibroblast activation protein alpha) [NCBI Gene 2191], PDPN (podoplanin) [NCBI Gene 10630], CD200 (CD200 molecule) [NCBI Gene 4345]
- **Proteins:** Tnc (tenascin C), CSF2 (colony stimulating factor 2), CSF1 (colony stimulating factor 1), IL6 (interleukin 6), MMP3 (matrix metallopeptidase 3), IL1B (interleukin 1 beta), CCL2 (C-C motif chemokine ligand 2), CX3CL1 (C-X3-C motif chemokine ligand 1), COL1A1 (collagen type I alpha 1 chain), COL1A2 (collagen type I alpha 2 chain), COL3A1 (collagen type III alpha 1 chain), FAP (fibroblast activation protein alpha), PDPN (podoplanin)
- **Diseases:** giant cell arteritis (MONDO:0008538), GCA (MONDO:0008538)

## Full-text entities

- **Genes:** COL3A1 (collagen type III alpha 1 chain) [NCBI Gene 1281] {aka EDS4A, EDSVASC, PMGEDSV}, ACTA1 (actin alpha 1, skeletal muscle) [NCBI Gene 58] {aka ACTA, ASMA, CFTD, CFTD1, CFTDM, CMYO2A}, FAP (fibroblast activation protein alpha) [NCBI Gene 2191] {aka DPPIV, FAPA, FAPalpha, SIMP}, CX3CL1 (C-X3-C motif chemokine ligand 1) [NCBI Gene 6376] {aka ABCD-3, C3Xkine, CXC3, CXC3C, NTN, NTT}, PDPN (podoplanin) [NCBI Gene 10630] {aka AGGRUS, D2-40, GP36, GP40, Gp38, HT1A-1}, CSF1 (colony stimulating factor 1) [NCBI Gene 1435] {aka CSF-1, MCSF, PG-M-CSF}, CD200 (CD200 molecule) [NCBI Gene 4345] {aka MOX1, MOX2, MRC, OX-2}, CD68 (CD68 molecule) [NCBI Gene 968] {aka GP110, LAMP4, SCARD1}, TNC (tenascin C) [NCBI Gene 3371] {aka 150-225, DFNA56, GMEM, GP, HXB, JI}, COL1A2 (collagen type I alpha 2 chain) [NCBI Gene 1278] {aka EDSARTH2, EDSCV, OI4}, THY1 (Thy-1 cell surface antigen) [NCBI Gene 7070] {aka CD90, CDw90}, MRC1 (mannose receptor C-type 1) [NCBI Gene 4360] {aka CD206, CLEC13D, CLEC13DL, MMR, MRC1L1, bA541I19.1}, MMP1 (matrix metallopeptidase 1) [NCBI Gene 4312] {aka CLG}, FN1 (fibronectin 1) [NCBI Gene 2335] {aka CIG, ED-B, FINC, FN, FNZ, GFND}, FOLR2 (folate receptor beta) [NCBI Gene 2350] {aka BETA-HFR, FBP, FBP/PL-1, FR-BETA, FR-P3, FRbeta}, COL1A1 (collagen type I alpha 1 chain) [NCBI Gene 1277] {aka CAFYD, EDSARTH1, EDSC, OI1, OI2, OI3}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, MMP3 (matrix metallopeptidase 3) [NCBI Gene 4314] {aka CHDS6, MMP-3, SL-1, STMY, STMY1, STR1}, CCL2 (C-C motif chemokine ligand 2) [NCBI Gene 6347] {aka GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1}, CSF2 (colony stimulating factor 2) [NCBI Gene 1437] {aka CSF, GMCSF}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}
- **Diseases:** vasculitis (MESH:D014657), inflammation (MESH:D007249), GCA (MESH:D013700)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13017568/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13017568/full.md

## References

34 references — full list in the complete paper: https://tomesphere.com/paper/PMC13017568/full.md

---
Source: https://tomesphere.com/paper/PMC13017568